Literature DB >> 25547506

Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer.

Guilhem Bousquet1, François Darrouzain2, Cédric de Bazelaire3, David Ternant2, Emmanuel Barranger4, Sabine Winterman5, Isabelle Madelaine-Chambin6, Jean-Baptiste Thiebaut7, Marc Polivka8, Gilles Paintaud2, Stéphane Culine9, Anne Janin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25547506     DOI： 10.1200/JCO.2012.44.8894

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Authors:  Eleonora Teplinsky; Francisco J Esteva
Journal:  Curr Oncol Rep       Date:  2015-10       Impact factor: 5.075

Review 2.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

Review 3.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

Review 4.  Systemic therapy for brain metastases.

Authors:  Jonathan W Rick; Maryam Shahin; Ankush Chandra; Cecilia Dalle Ore; John K Yue; Alan Nguyen; Garima Yagnik; Soumya Sagar; Saman Arfaie; Manish K Aghi
Journal:  Crit Rev Oncol Hematol       Date:  2019-07-22       Impact factor: 6.312

Review 5.  Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies.

Authors:  Evelyn M Brosnan; Carey K Anders
Journal:  Ann Transl Med       Date:  2018-05

Review 6.  Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors:  Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal:  Oncotarget       Date:  2017-08-16

7.  Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.

Authors:  Tom Wei-Wu Chen; I-Shiow Jan; Dwang-Ying Chang; Ching-Hung Lin; I-Chun Chen; Ho-Min Chen; Ann-Lii Cheng; Yen-Shen Lu
Journal:  J Neurooncol       Date:  2020-04-29       Impact factor: 4.130

8.  Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

Authors:  Leticia De Mattos-Arruda; Charlotte K Y Ng; Salvatore Piscuoglio; Maria Gonzalez-Cao; Raymond S Lim; Maria R De Filippo; Nicola Fusco; Anne M Schultheis; Carolina Ortiz; Santiago Viteri; Alexandra Arias; Gabriel S Macedo; Mafalda Oliveira; Patricia Gomez; Cristina Teixidó; Paolo Nuciforo; Vicente Peg; Cristina Saura; Santiago Ramon Y Cajal; Francesc Tresserra Casas; Britta Weigelt; Javier Cortes; Joan Seoane; Jorge S Reis-Filho
Journal:  Oncotarget       Date:  2018-04-17

Review 9.  Molecular and cellular mechanisms underlying brain metastasis of breast cancer.

Authors:  Mari Hosonaga; Hideyuki Saya; Yoshimi Arima
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

10.  Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.

Authors:  Jing Wen; Di Wu; Meng Qin; Chaoyong Liu; Lan Wang; Duo Xu; Harry V Vinters; Yang Liu; Emiko Kranz; Xin Guan; Guibo Sun; Xiaobo Sun; YooJin Lee; Otoniel Martinez-Maza; Daniel Widney; Yunfeng Lu; Irvin S Y Chen; Masakazu Kamata
Journal:  Nat Biomed Eng       Date:  2019-08-05       Impact factor: 25.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.